Skip to content

Formative Phase of Reducing Hazardous Alcohol Use & HIV Viral Load

Formative Phase of Reducing Hazardous Alcohol Use & HIV Viral Load: An RCT in ART Clinics in Vietnam

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02153216
Acronym
F-REDART
Enrollment
40
Registered
2014-06-02
Start date
2014-05-31
Completion date
2016-01-31
Last updated
2016-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Drinking, Alcohol Use Among ART Clients, Alcohol Use Norms

Brief summary

This study is the Formative Phase of a larger study; once this phase is completed, enrollment into the randomized controlled trial (RCT Phase) will begin. The primary objective of the Formative Phase is to gain a better understanding of the context in which drinking alcohol among ART client in Vietnam occurs, in order to culturally tailor the intervention to be tested in the RCT Phase. Formative Phase activities will consist of up to 40 in-depth interviews with hazardous drinkers who are either: a) ART clients in one of the ART clinics in Thai Nguyen, or b) who are people who inject drugs (PWID) that are not recruited from the ART clinics (whom we will refer to as general population PWID).

Interventions

None listed

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 49 Years
Healthy volunteers
No

Inclusion criteria

* being 18-49 years of age; * having an AUDIT score ≥ 8 (hazardous alcohol use); * being a current ART client at one of the Thai Nguyen ART clinics or a general population PWID; * being capable of providing voluntary informed consent.

Exclusion criteria

* being unable to participate in study activities due to psychological disturbance, cognitive impairment or threatening behavior; * currently participating in other HIV, drug use or alcohol studies.

Design outcomes

Primary

MeasureTime frameDescription
Frequency of heavy drinking episodesduring interviewsThis will be an assessment of how and why individuals engage in heavy drinking. As part of this exploration, we will assess: * number of standard drinks consumed on those days that an individual drank * number of days on which alcohol was consumed beyond recommended levels

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026